Skip to main content
Top
Published in: Trials 1/2019

Open Access 01-12-2019 | Crohn's Disease | Study protocol

The bowel preparation for magnetic resonance enterography in patients with Crohn’s disease: study protocol for a randomized controlled trial

Authors: Min Dai, Ting Zhang, Qianqian Li, Bota Cui, Liyuan Xiang, Xiao Ding, Rong Rong, Jianling Bai, Jianguo Zhu, Faming Zhang

Published in: Trials | Issue 1/2019

Login to get access

Abstract

Background

Adequate bowel preparation is required for magnetic resonance enterography (MRE), which can be achieved by administering contrast solution after mid-gut tubing or taking contrast solution orally. We present the design of randomized controlled trial (RCT) to compare the efficacy and compliance of bowel preparation between mid-gut tubing and oral administering for MRE in patients with Crohn’s disease (CD).

Methods/design

This is an open-label, multicenter RCT. Ninety-six patients with CD in need of MRE examination and mid-gut tubing (prepared for fecal microbiota transplantation and/or enteral nutrition), aged ≥ 14 years, will be included. Patients will be randomized 1:1 into either bowel preparation by oral administering (oral group) or bowel preparation through mid-gut transendoscopic enteral tubing (TET) (tubing group). The primary outcome measures are: (1) degree of discomfort before/during/after bowel preparation for MRE using a visual 5-grade scale (1 = few, 5 = very severe); and (2) grade of bowel distention evaluated by a 5-grade scale (1 = 0–20% segmental distention, 2 = 20–40% distention, 3 = 40–60% distention, 4 = 60–80% distention, 5 = 80–100% distention). The secondary outcome measure is the accuracy of lesion detection through MRE confirmed by colonoscopy which is evaluated by a 5-point scale.

Discussion

The outcome of this study is expected to provide a novel effective clinical protocol of bowel preparation for MRE in patients with CD. We hope to highlight the concept of physician–patient satisfaction based on different methods of bowel preparation for MRE.

Trial registration

ClinicalTrials.gov, NCT03541733. Registered on 30 May 2018.
Appendix
Available only for authorised users
Literature
1.
go back to reference Latella G, Papi C. Crucial steps in the natural history of inflammatory bowel disease. World J Gastroenterol. 2012;18(29):3790–9.CrossRef Latella G, Papi C. Crucial steps in the natural history of inflammatory bowel disease. World J Gastroenterol. 2012;18(29):3790–9.CrossRef
2.
go back to reference Maccioni F, Viscido A, Broglia L, Marrollo M, Masciangelo R, Caprilli R, et al. Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging. 2000;25(3):219–28.CrossRef Maccioni F, Viscido A, Broglia L, Marrollo M, Masciangelo R, Caprilli R, et al. Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging. 2000;25(3):219–28.CrossRef
3.
go back to reference Grand DJ, Beland M, Harris A. Magnetic resonance enterography. Radiol Clin N Am. 2013;51(1):99–112.CrossRef Grand DJ, Beland M, Harris A. Magnetic resonance enterography. Radiol Clin N Am. 2013;51(1):99–112.CrossRef
4.
go back to reference Panes J, Bouzas R, Chaparro M, Garcia-Sanchez V, Gisbert JP, Martinez de Guerenu B, et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease. Aliment Pharmacol Ther. 2011;34(2):125–45.CrossRef Panes J, Bouzas R, Chaparro M, Garcia-Sanchez V, Gisbert JP, Martinez de Guerenu B, et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease. Aliment Pharmacol Ther. 2011;34(2):125–45.CrossRef
5.
go back to reference Koh DM, Miao Y, Chinn RJ, Amin Z, Zeegen R, Westaby D, et al. MR imaging evaluation of the activity of Crohn's disease. AJR Am J Roentgenol. 2001;177(6):1325–32.CrossRef Koh DM, Miao Y, Chinn RJ, Amin Z, Zeegen R, Westaby D, et al. MR imaging evaluation of the activity of Crohn's disease. AJR Am J Roentgenol. 2001;177(6):1325–32.CrossRef
6.
go back to reference Wagner M, Ko HM, Chatterji M, Besa C, Torres J, Zhang X, et al. Magnetic resonance imaging predicts histopathological composition of ileal Crohn’s disease. J Crohns Colitis. 2018;12(6):718–29.CrossRef Wagner M, Ko HM, Chatterji M, Besa C, Torres J, Zhang X, et al. Magnetic resonance imaging predicts histopathological composition of ileal Crohn’s disease. J Crohns Colitis. 2018;12(6):718–29.CrossRef
7.
go back to reference Towbin AJ, Sullivan J, Denson LA, Wallihan DB, Podberesky DJ. CT and MR enterography in children and adolescents with inflammatory bowel disease. Radiographics. 2013;33(7):1843–60.CrossRef Towbin AJ, Sullivan J, Denson LA, Wallihan DB, Podberesky DJ. CT and MR enterography in children and adolescents with inflammatory bowel disease. Radiographics. 2013;33(7):1843–60.CrossRef
8.
go back to reference Fornasa F, Benassuti C, Benazzato L. Role of magnetic resonance enterography in differentiating between fibrotic and active inflammatory small bowel stenosis in patients with Crohn’s disease. J Clin Imaging Sci. 2011;1:35.CrossRef Fornasa F, Benassuti C, Benazzato L. Role of magnetic resonance enterography in differentiating between fibrotic and active inflammatory small bowel stenosis in patients with Crohn’s disease. J Clin Imaging Sci. 2011;1:35.CrossRef
9.
go back to reference Negaard A, Paulsen V, Sandvik L, Berstad AE, Borthne A, Try K, et al. A prospective randomized comparison between two MRI studies of the small bowel in Crohn’s disease, the oral contrast method and MR enteroclysis. Eur Radiol. 2007;17(9):2294–301.CrossRef Negaard A, Paulsen V, Sandvik L, Berstad AE, Borthne A, Try K, et al. A prospective randomized comparison between two MRI studies of the small bowel in Crohn’s disease, the oral contrast method and MR enteroclysis. Eur Radiol. 2007;17(9):2294–301.CrossRef
10.
go back to reference Masselli G, Casciani E, Polettini E, Gualdi G. Comparison of MR enteroclysis with MR enterography and conventional enteroclysis in patients with Crohn’s disease. Eur Radiol. 2008;18(3):438–47.CrossRef Masselli G, Casciani E, Polettini E, Gualdi G. Comparison of MR enteroclysis with MR enterography and conventional enteroclysis in patients with Crohn’s disease. Eur Radiol. 2008;18(3):438–47.CrossRef
11.
go back to reference Long C, Yu Y, Cui B, Jagessar SAR, Zhang J, Ji G, et al. A novel quick transendoscopic enteral tubing in mid-gut: technique and training with video. BMC Gastroenterol. 2018;18(1):37.CrossRef Long C, Yu Y, Cui B, Jagessar SAR, Zhang J, Ji G, et al. A novel quick transendoscopic enteral tubing in mid-gut: technique and training with video. BMC Gastroenterol. 2018;18(1):37.CrossRef
12.
go back to reference Cui B, Feng Q, Wang H, Wang M, Peng Z, Li P, et al. Fecal microbiota transplantation through mid-gut for refractory Crohn’s disease: safety, feasibility, and efficacy trial results. J Gastroenterol Hepatol. 2015;30(1):51–8.CrossRef Cui B, Feng Q, Wang H, Wang M, Peng Z, Li P, et al. Fecal microbiota transplantation through mid-gut for refractory Crohn’s disease: safety, feasibility, and efficacy trial results. J Gastroenterol Hepatol. 2015;30(1):51–8.CrossRef
13.
go back to reference He Z, Li P, Zhu J, Cui B, Xu L, Xiang J, et al. Multiple fresh fecal microbiota transplants induces and maintains clinical remission in Crohn’s disease complicated with inflammatory mass. Sci Rep. 2017;7(1):4753.CrossRef He Z, Li P, Zhu J, Cui B, Xu L, Xiang J, et al. Multiple fresh fecal microbiota transplants induces and maintains clinical remission in Crohn’s disease complicated with inflammatory mass. Sci Rep. 2017;7(1):4753.CrossRef
14.
go back to reference Zhang FM, Wang HG, Wang M, Cui BT, Fan ZN, Ji GZ. Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn's disease. World J Gastroenterol. 2013;19(41):7213–6.CrossRef Zhang FM, Wang HG, Wang M, Cui BT, Fan ZN, Ji GZ. Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn's disease. World J Gastroenterol. 2013;19(41):7213–6.CrossRef
15.
go back to reference Ajaj W, Goehde SC, Schneemann H, Ruehm SG, Debatin JF, Lauenstein TC. Oral contrast agents for small bowel MRI: comparison of different additives to optimize bowel distension. Eur Radiol. 2004;14(3):458–64.CrossRef Ajaj W, Goehde SC, Schneemann H, Ruehm SG, Debatin JF, Lauenstein TC. Oral contrast agents for small bowel MRI: comparison of different additives to optimize bowel distension. Eur Radiol. 2004;14(3):458–64.CrossRef
16.
go back to reference Borthne AS, Abdelnoor M, Storaas T, Pierre-Jerome C, Klow NE. Osmolarity: a decisive parameter of bowel agents in intestinal magnetic resonance imaging. Eur Radiol. 2006;16(6):1331–6.CrossRef Borthne AS, Abdelnoor M, Storaas T, Pierre-Jerome C, Klow NE. Osmolarity: a decisive parameter of bowel agents in intestinal magnetic resonance imaging. Eur Radiol. 2006;16(6):1331–6.CrossRef
17.
go back to reference Kuehle CA, Ajaj W, Ladd SC, Massing S, Barkhausen J, Lauenstein TC. Hydro-MRI of the small bowel: effect of contrast volume, timing of contrast administration, and data acquisition on bowel distention. AJR Am J Roentgenol. 2006;187(4):W375–85.CrossRef Kuehle CA, Ajaj W, Ladd SC, Massing S, Barkhausen J, Lauenstein TC. Hydro-MRI of the small bowel: effect of contrast volume, timing of contrast administration, and data acquisition on bowel distention. AJR Am J Roentgenol. 2006;187(4):W375–85.CrossRef
18.
go back to reference Zhu J, Zhang F, Zhou J, Li H. Assessment of therapeutic response in Crohn’s disease using quantitative dynamic contrast enhanced MRI (DCE-MRI) parameters: A preliminary study. Medicine (Baltimore). 2017;96(32):e7759.CrossRef Zhu J, Zhang F, Zhou J, Li H. Assessment of therapeutic response in Crohn’s disease using quantitative dynamic contrast enhanced MRI (DCE-MRI) parameters: A preliminary study. Medicine (Baltimore). 2017;96(32):e7759.CrossRef
19.
go back to reference Zhu J, Zhang F, Luan Y, Cao P, Liu F, He W, et al. Can dynamic contrast-enhanced MRI (DCE-MRI) and diffusion-weighted MRI (DW-MRI) evaluate inflammation disease: a preliminary study of Crohn’s disease. Medicine (Baltimore). 2016;95(14):e3239.CrossRef Zhu J, Zhang F, Luan Y, Cao P, Liu F, He W, et al. Can dynamic contrast-enhanced MRI (DCE-MRI) and diffusion-weighted MRI (DW-MRI) evaluate inflammation disease: a preliminary study of Crohn’s disease. Medicine (Baltimore). 2016;95(14):e3239.CrossRef
20.
go back to reference Negaard A, Sandvik L, Berstad AE, Paulsen V, Lygren I, Borthne A, et al. MRI of the small bowel with oral contrast or nasojejunal intubation in Crohn’s disease: randomized comparison of patient acceptance. Scand J Gastroenterol. 2008;43(1):44–51.CrossRef Negaard A, Sandvik L, Berstad AE, Paulsen V, Lygren I, Borthne A, et al. MRI of the small bowel with oral contrast or nasojejunal intubation in Crohn’s disease: randomized comparison of patient acceptance. Scand J Gastroenterol. 2008;43(1):44–51.CrossRef
21.
go back to reference Bharucha AE, Fidler JL, Huprich JE, Ratuapli SK, Holmes DR, Riederer SJ, et al. A prospective randomized controlled study of erythromycin on gastric and small intestinal distention: implications for MR enterography. Eur J Radiol. 2014;83(11):2001–6.CrossRef Bharucha AE, Fidler JL, Huprich JE, Ratuapli SK, Holmes DR, Riederer SJ, et al. A prospective randomized controlled study of erythromycin on gastric and small intestinal distention: implications for MR enterography. Eur J Radiol. 2014;83(11):2001–6.CrossRef
22.
go back to reference Borthne AS, Abdelnoor M, Hellund JC, Geitung JT, Storaas T, Gjesdal KI, et al. MR imaging of the small bowel with increasing concentrations of an oral osmotic agent. Eur Radiol. 2005;15(4):666–71.CrossRef Borthne AS, Abdelnoor M, Hellund JC, Geitung JT, Storaas T, Gjesdal KI, et al. MR imaging of the small bowel with increasing concentrations of an oral osmotic agent. Eur Radiol. 2005;15(4):666–71.CrossRef
23.
go back to reference Sinha R, Rawat S. MRI enterography with divided dose oral preparation: Effect on bowel distension and diagnostic quality. Indian J Radiol Imaging. 2013;23(1):86–91.CrossRef Sinha R, Rawat S. MRI enterography with divided dose oral preparation: Effect on bowel distension and diagnostic quality. Indian J Radiol Imaging. 2013;23(1):86–91.CrossRef
24.
go back to reference Dillman JR, Adler J, Zimmermann EM, Strouse PJ. CT enterography of pediatric Crohn disease. Pediatr Radiol. 2010;40(1):97–105.CrossRef Dillman JR, Adler J, Zimmermann EM, Strouse PJ. CT enterography of pediatric Crohn disease. Pediatr Radiol. 2010;40(1):97–105.CrossRef
25.
go back to reference O’Donovan AN, Somers S, Farrow R, Mernagh JR, Sridhar S. MR imaging of anorectal Crohn disease: a pictorial essay. Radiographics. 1997;17(1):101–7.CrossRef O’Donovan AN, Somers S, Farrow R, Mernagh JR, Sridhar S. MR imaging of anorectal Crohn disease: a pictorial essay. Radiographics. 1997;17(1):101–7.CrossRef
26.
go back to reference Laniado M, Makowiec F, Dammann F, Jehle EC, Claussen CD, Starlinger M. Perianal complications of Crohn disease: MR imaging findings. Eur Radiol. 1997;7(7):1035–42.CrossRef Laniado M, Makowiec F, Dammann F, Jehle EC, Claussen CD, Starlinger M. Perianal complications of Crohn disease: MR imaging findings. Eur Radiol. 1997;7(7):1035–42.CrossRef
27.
go back to reference Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Prassopoulos P. MR enteroclysis: technical considerations and clinical applications. Eur Radiol. 2002;12(11):2651–8.PubMed Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Prassopoulos P. MR enteroclysis: technical considerations and clinical applications. Eur Radiol. 2002;12(11):2651–8.PubMed
28.
go back to reference Schreyer AG, Geissler A, Albrich H, Scholmerich J, Feuerbach S, Rogler G, et al. Abdominal MRI after enteroclysis or with oral contrast in patients with suspected or proven Crohn’s disease. Clin Gastroenterol Hepatol. 2004;2(6):491–7.CrossRef Schreyer AG, Geissler A, Albrich H, Scholmerich J, Feuerbach S, Rogler G, et al. Abdominal MRI after enteroclysis or with oral contrast in patients with suspected or proven Crohn’s disease. Clin Gastroenterol Hepatol. 2004;2(6):491–7.CrossRef
Metadata
Title
The bowel preparation for magnetic resonance enterography in patients with Crohn’s disease: study protocol for a randomized controlled trial
Authors
Min Dai
Ting Zhang
Qianqian Li
Bota Cui
Liyuan Xiang
Xiao Ding
Rong Rong
Jianling Bai
Jianguo Zhu
Faming Zhang
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Trials / Issue 1/2019
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-018-3101-x

Other articles of this Issue 1/2019

Trials 1/2019 Go to the issue